BAY-474

CAS No. 1033767-86-0

BAY-474( —— )

Catalog No. M22726 CAS No. 1033767-86-0

BAY-474 is an inhibitor of tyrosine-protein kinase c-Met. It acts as an epigenetics probe.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 77 In Stock
5MG 65 In Stock
10MG 115 In Stock
25MG 215 In Stock
50MG 304 In Stock
100MG 425 In Stock
200MG 572 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BAY-474
  • Note
    Research use only, not for human use.
  • Brief Description
    BAY-474 is an inhibitor of tyrosine-protein kinase c-Met. It acts as an epigenetics probe.
  • Description
    BAY-474 is an inhibitor of tyrosine-protein kinase c-Met. It acts as an epigenetics probe.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    c-Met/HGFR
  • Recptor
    c-Met
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1033767-86-0
  • Formula Weight
    289.33
  • Molecular Formula
    C17H15N5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:120 mg/mL?(414.75 mM;?Need ultrasonic)
  • SMILES
    Cc1n[nH]c2ccc(cc12)C1C(C#N)=C(C)NC(C)=C1C#N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Müller S, et al. Donated chemical probes for open science. Elife. 2018 Apr 20;7. pii: e34311.
molnova catalog
related products
  • TAE226

    NVP-TAE226 is a potent FAK inhibitor with IC50 of 5.5 nM and modestly potent to Pyk2(IC50=3.5 nM); 10- to 100-fold less potent against InsR, IGF-1R, ALK, and c-Met.

  • Telisotuzumab

    Telisotuzumab(ABT-700) is a humanized recombinant antibody targeting the therapeutic hepatocyte growth factor receptor (MET) with high affinity for c-Met.Telisotuzumab has inhibitory effects on c-Met signaling and antitumor activity.

  • PHA-665752

    PHA-665752 is a potent, selective, ATP-competitive c-Met inhibitor with Ki/IC50 of 4/9 nM.